✨ Free AI Report
Cambrex Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Cambrex Corporation
Company Research

Cambrex Corporation: Business Overview, Financials & Competitive Analysis

Cambrex Corporation is a leading provider of contract development and manufacturing services for the pharmaceutical and biotechnology sectors. The company generated annual revenue of $717.6 million in 2026 and serves ...

Analyst-debate audio for Cambrex Corporation

AskCyborg analysts argue the bull and bear cases for Cambrex Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Solid

Cyborg Score thesis

Well-positioned CDMO capitalizing on pharmaceutical industry consolidation and domestic supply chain reshoring trends through...

Read the full analyst-debate transcript →
Industry Pharmaceuticals
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Cambrex Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Cambrex Corporation Overview

Pro stress-test →

Cambrex Corporation is a leading provider of contract development and manufacturing services for the pharmaceutical and biotechnology sectors. The company generated annual revenue of $717.6 million in 2026 and serves as a critical infrastructure provider supporting drug development and manufacturing across the pharmaceutical industry's full product lifecycle.

Strategic Profile

Pro stress-test →

The company is expanding its operational footprint across the United States and Europe to meet rising global demand for high-quality drug development and manufacturing solutions, while enhancing its ability to support customers throughout the entire product lifecycle. Cambrex specializes in complex small molecule development projects and active pharmaceutical ingredient (API) manufacturing.

Competitive Landscape

Pro stress-test →

Cambrex competes with firms including Theorem Clinical Research, Recipharm, CordenPharma, Catalent, and Actylis in the CDMO market. The company differentiates through geographic diversification, specialized API capabilities, and integrated drug development services spanning small molecules to peptides.

Industry Context

Cambrex Corporation operates in Pharmaceuticals.

Key facts

Headquarters: East Rutherford, New Jersey · Employees: 1,744 · Revenue: $717.6M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Cambrex Corporation.

  • (March 2026) Completed initial engineering studies for a new large-scale API manufacturing plant in Charles City, Iowa, representing progress toward a $120 million investment in expanding US API manufacturing capabilities.
  • Actively investing in upgrading US facilities to increase production capacity and improve technological capabilities, with focus on complex small molecule development and API manufacturing.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Completed initial engineering studies for new large-scale API manufacturing plant in Charles City, Iowa
  • March 2026Announced significant expansion of US and European operations to meet growing demand
  • +1 moreTrack every material event for Cambrex Corporation as it happens. Explore monitoring →
Get alerted when Cambrex Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

CatalentGlobal CDMO providing drug development and manufacturing services→CordenPharmaContract development and manufacturing organization→RecipharmEuropean CDMO and specialized pharma services provider→Theorem Clinical ResearchClinical research and manufacturing services→

Compare Cambrex Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Cambrex Corporation operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Cambrex Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Cambrex Corporation and its top competitor on Cyborg Score”
“What did Cambrex Corporation do this quarter?”
“Is Cambrex Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Cambrex Corporation do?+
Cambrex Corporation is a leading provider of contract development and manufacturing services for the pharmaceutical and biotechnology sectors. The company generated annual revenue of $717.6 million in 2026 and serves ...
What is Cambrex Corporation's Cyborg Score?+
Cambrex Corporation has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Cambrex Corporation's main competitors?+
Named competitors include Catalent, CordenPharma, Recipharm, Theorem Clinical Research. The full competitive landscape is in the AskCyborg report.
How can I get the full Cambrex Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Cambrex Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Cambrex Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Novartis AG7Recordati Industria Chimica e Farmaceutica SpA6CSPC Innovation Pharmaceutical Co., Ltd.